Press Coverage

77% of Patients Ignore FDA Safety Recommendations for Ambien

Article on study published in JAMA Internal Medicine that was co-authored by ISMP's Senior Scientist summarizes safety concerns regarding Ambien use, including combining two or more drugs that depress the central nervous system, sustained instead of short-term use, and a higher than recommended dose or starting dose for women and older patients.

For the full text of the article, visit Healio online.

More News

Healthcare Leaders Urged to Avoid Severity Bias, Establish Just Culture In the wake of recent criminal charges being filed against a registered nurse in Tennessee who was involved in a fatal medication error, the Institute for Safe Medication Practices (ISMP) is emphasizing that the focus should be